Immunonutrition supplementation for resectable gastric cancer during standard neoadjuvant chemotherapy of FLOT. A proof-of-concept protocol: I-SUPPLY-Reference-Cited by-同舟云学术

Immunonutrition supplementation for resectable gastric cancer during standard neoadjuvant chemotherapy of FLOT. A proof-of-concept protocol: I-SUPPLY

Published:2024-03 Issue: Volume:3 Page:100036
ISSN:2949-8198
Container-title:ESMO Gastrointestinal Oncology
language:en
Short-container-title:ESMO Gastrointestinal Oncology

Author:

Pusceddu V.^ORCID,Donisi C.,Pretta A.^ORCID,Loi F.,Badas R.,Ziranu P.,Puzzoni M.,Lai E.^ORCID,Mariani S.,Palmas E.^ORCID,Pozzari M.,Cimbro E.,D’Agata A.P.^ORCID,Pinto S.,Coghe F.,Bergamini S.,Fanni D.^ORCID,Faa G.,Yoshino T.^ORCID,Scartozzi M.

Funder

Ministero dell’Istruzione, dell’Università e della Ricerca

Publisher

Elsevier BV

Reference13 articles.

1. Immune infiltration profiling in gastric cancer and their clinical implications;Ren;Cancer Sci,2021

2. International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study;Pagès;Lancet,2018

3. Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5FU based adjuvant chemotherapy;Yun;Cancer Immunol Immunother,2020

4. The translational machinery of human CD4(+) T cells is poised for activation and controls the switch from quiescence to metabolic remodeling;Ricciardi;Cell Metab,2018

5. Fueling immunity: insights into metabolism and lymphocyte function;Pearce;Science,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cuproptosis‐related gene DLAT is a biomarker of the prognosis and immune microenvironment of gastric cancer and affects the invasion and migration of cells;Cancer Medicine;2024-07